ALK and anaplastic large cell lymphoma: As shown in Fig. 3, four secondary mutations were identified in Crizotinib-resistant ALK+ALCL cell lines, with one mutation (G329A) occurring in Karpas 299 cells while 3 mutations (G262R, K551R and D589E) were observed in SupM2.